首页> Nature communications> Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection.

Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection.

导出 OA

翻译打印收藏纠错

第一作者： Ge,Song

第一单位： Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.;IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.;Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.

作者： Ge,Song ^[1] ; Wan-Ting,He ^[1] ; Sean,Callaghan ^[1] ; Fabio,Anzanello ^[1] ; Deli,Huang ^[2] ; James,Ricketts ^[2] ; Jonathan L,Torres ^[3] ; Nathan,Beutler ^[2] ; Linghang,Peng ^[2] ; Sirena,Vargas ^[1] ; Jon,Cassell ^[1] ; Mara,Parren ^[2] ; Linlin,Yang ^[2] ; Caroline,Ignacio ^[4] ; Davey M,Smith ^[4] ; James E,Voss ^[2] ; David,Nemazee ^[2] ; Andrew B,Ward ^[5] ; Thomas,Rogers ^[6] ; Dennis R,Burton ^[7] ; Raiees,Andrabi ^[8]

作者单位： Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.;IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.;Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. ^[1] Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. ^[2] Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA. ^[3] Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. ^[4] IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.;Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.;Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA. ^[5] Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.;Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. ^[6] Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.;IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.;Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.;Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, USA. burton@scripps.edu. ^[7] Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. andrabi@scripps.edu.;IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. andrabi@scripps.edu.;Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. andrabi@scripps.edu. ^[8]